The most important organ in the management of the project and the decision making team is the Supervisory board, chaired by the coordinator, Lia van der Hoek. It is composed of one representative per beneficiary. The board is responsible for 1) overseeing recruitment 2) all research activities 3) reviewing Personal Career Development Plans, 4) discussing contingency plans in case of unexpected difficulties, 5) making strategies for dissemination, intellectual property protection and exploitation of results, 6) adjusting training schedules where needed.
There will be a small Executive team (Lia van der Hoek, Patricia Sastre, and Volker Thiel) responsible for the day-to-day management and will handle urgent scientific issues and are the first to act in conflicts
The Administration Centre (Jos Karlas, Don van Velzen) takes care of the website, internal communication and supports the coordinator with the financial and administrative management, including the execution of payments. Furthermore the Centre assists in organizing the annual HONOURs meetings, provides administrative and managing support to the Supervisory board (e.g overview of trainings completed, overview of publications/disseminations etc.) and accommodates the executive team where needed.
The ESR platform consists of all ESRs of HONOURs. Each year they select one representative who will be part of the Supervisory Board. She or he will be responsible for communicating the views from her/his colleagues.
The Ethical board (Martin Beer, Stephen Leib, Lia van der Hoek, and Marc Van Ranst) will monitor and guide the application of ethical permissions, the handling of dangerous pathogens, but also the important ethical issues that are encountered in case an outbreak occurs. At all stages the HONOURs ethical board will take local and international legislations into account. An independent Ethics Advisor (Prof dr Laurent Kaiser, professor of medicine at the University of Geneva, Head of the Division of Infectious Diseases and Director of the Laboratory of Virology at the Geneva University Hospitals) will oversee the implementation of the ethical concerns.
Advisory board: Prof dr. Caroline Tapparel (Medical Faculty, University of Geneva, Department of Internal Medicine Specialties) and Prof. dr. Paul Britton (The Pirbright Institute, Compton, UK ) will advise on student training and scientific matters.
The Exploitation board (Paul Vermeij, Lia van der Hoek, Patricia Sastre, and John Barr) will be the first structure to be contacted in case of exploitation and Intellectual Property (IP) protection. It is expected that HONOURs will generate significant new results, with relevant IP. The investigators together with the Technology Transfer Offices of the participating institutes and industrial beneficiaries will be responsible for identifying research results to be exploited and hence require protection.